What's New in Prevention of Cardiovascular Disease — December 16, 2008,
12:00 p.m. — 1:00 p.m. (EST)
Stanley Hazen, MD, PhD
Section Head, Preventive Cardiology & Rehabilitation
Cleveland Clinic Department of Cardiovascular Medicine
If you have heart or vascular disease - you may have many questions about how to stop it from progressing - or if you have a family member who has a heart condition - you may wonder - will this happen to me? It can become confusing - what foods should I eat? What should I avoid? should I start exercising? What about supplements? What do all the risk factor and blood tests mean? Join us as we chat with Dr. Stanely Hazen, Section Head of Preventive Cardiology and Rehabilitation Director for the Center for Cardiovascular Diagnostics and Prevention, and a staff physician in the Departments of Cell Biology and Cardiovascular Medicine at Cleveland Clinic as he answers your questions about risk factors, prevention, and how to live a heart healthy life.
Dr. Stanley Hazen is the Head of the Section for Preventive Cardiology & Rehabilitation, Director for the Center for Cardiovascular Diagnostics and Prevention, and a staff physician in the Departments of Cell Biology and Cardiovascular Medicine at the Cleveland Clinic Foundation. Dr. Hazen is board certified as a Diplomat of both the American Board of Internal Medicine and the National Board of Medical Examiners. He has completed additional training in Endocrinology, Diabetes and Metabolism. He sees patients within the Preventive Cardiology Clinic, specializing in care of patients with hyperlipidemia, diabetes and hypertension. His research interests include understanding the role of inflammation and oxidant stress in the pathogenesis of atherosclerosis and other inflammatory diseases. He is an expert in the biochemistry of leukocyte peroxidases, free radicals and reactive oxygen species and mechanisms of oxidative damage.
Dr. Hazen has published over 150 peer-reviewed articles, invited reviews and book chapters in the fields of atherosclerosis, oxidation and inflammation chemistry, and cardiovascular biomarkers. He has received many honors and awards for his research work, which has contributed to new understandings of inflammation in cardiovascular disease, and the development of new diagnostic and treatment tools. He is listed as a co-inventor on multiple patents for his work in diagnosing asthma, treating inflammation and associated complications, and identifying patients at increased risk for cardiovascular disease. He has been principal investigator on numerous grant supported research projects related to his specialty interests.
